Pharmacy Sector SECTOR COMMITMENT TO END TB

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

Common/shared responsibilities between jobs.
The Re- emerging Threat of TB Magnitude of the Problem Associated Factors & challenges Current strategies Aamod Asmita Dr. Bala Dr. Arun Dr. Samraj Nisha.
Improving diagnosis TB laboratory strengthening.
Part A: Module A5 Session 2
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Role of the laboratory in disease surveillance
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Community pharmacy. Actions of community pharmacists in society Procurement of medicines that are suitable for human consumption Storage of medicines.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Role of Pharmacist in Malaria Control
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
| ICIUM2011 MALARIA/TB PANEL DISCUSSION 17 NOVEMBER 2011 DR HODA Y. ATTA Scaling up community management of malaria - challenges and successes in EMRO.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Mobile content for frontline health workers mHealth Workshop October 15 th 2013.
Establishing COPD Patient Organizations Mariadelaide Franchi, ICC Co-Chair, Italy Artwork by: Pierluigi Diano, Micaela Mau.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Mobilizing Single Practice Providers for DOTS Network Service Delivery Marilou P. Costello, PhD Elmer S. Soriano, MD Philippine Tuberculosis Initiative.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Pharmaceutical Society of Ireland – The Pharmacy Regulator The Role of the Pharmacist in Self Care Telephone: Shrewsbury Rd Fax:
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Current harm reduction program at outreach
WHO Medicines Work in Countries: The Kenya Example
At the crossroads: deinstitutionalization in Bulgaria
This is an archived document.
TB/HIV surveillance : Who is going to get the job done?
Find and Treat All Missing Persons with TB
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Knowledge gaps in formulating TB Control Policies for Prisons
Issues on Dispensing Dr Percy Mahlathi.
Essential Drugs and Medicines Policy
Why does WWF engage with civil society?
TB epidemiological situation in Kyrgyzstan
Pharmacy practice and the healthcare system Ola Ali Nassr
National Cancer Center
5th edition NTP MANUAL OF PROCEDURES Introduction and Highlights
From TB control to integrated respiratory disease control
Essential Drugs and Medicines Policy
Access to Essential Medicines
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
Accredited Drug Dispensing Outlets (ADDOs): Improving Access to Quality Drugs and Services in Rural and Peri-urban Areas with Few.
The STOP TB Strategy – 2009 VISION: A TB-free world
Community Engagement to END TB Patient Support Group Sector.
Pharmacy Benefit Manager
33rd IUATLD World Conference on Lung Health
Hospital pharmacy.
Monitoring and Evaluation: A Review of Terms
5th edition NTP MANUAL OF PROCEDURES Chapter 1: Introduction
Presentation transcript:

Pharmacy Sector SECTOR COMMITMENT TO END TB #EndTBNowNa! Pharmacy Sector SECTOR COMMITMENT TO END TB “Business not-as-usual..”

“Business not-as-usual..” For the End TB Strategy to be successful, prioritizing and harnessing the power of private-sector retail drug outlets will be instrumental in accelerating the early detection and referral of the 3 million missing cases.  “Business not-as-usual..”

“Business not-as-usual..” Pharmacists constitute an important and essential part of the health work-force Pharmacists are the frontline health-care providers and often a first point of contact for people with symptoms of tuberculosis “Business not-as-usual..”

Game Changing Strategies #EndTBNowNa! Game Changing Strategies “Business not-as-usual..”

Game Changing Strategy 1 Sustained professional development of the network of pharmacy professionals on adherence to anti-microbial resistance and dispensing ethics to include NO prescription NO dispensing of anti-TB drugs. “Business not-as-usual..”

Game Changing Strategy 2 Promote rational use of anti-TB medicines and ensure that quality assured medicines are procured and supplied. Ensure NO over the counter sale of anti-TB medicines and strictly comply with the NO prescription, NO dispensing policy “Business not-as-usual..”

Game Changing Strategy 3 Work with the DOH National Tuberculosis Program in the review and revision pharmacy school curricula to incorporate content on TB control and the role of pharmacy professionals and PPhA PDI Advocacy Group to continue participating and collaborating with the government and private institutions toward end-TB programs “Business not-as-usual..”

Game Changing Strategy 4 Referral of people with symptoms of TB to appropriate health-care facilities for early diagnosis; providing supportive supervision of TB patients including directly-observed treatment to promote adherence and prevent multidrug resistance “Business not-as-usual..”

Game Changing Strategy 5 Provision of education to patient and to family members on infection control and strategies to prevent and manage stigma. “Business not-as-usual..”

Key Issues Affecting the Sector #EndTBNowNa! Key Issues Affecting the Sector “Business not-as-usual..”

Key Issue Affecting the Sector 1 The Pharmacy DOTS Initiative implementation (PDI) conceptualized by the Philippine Tuberculosis Initiatives for the Private Sector (PhilTIPS) through USAID support in 2004 and later scaled up in 33 sites with a grant from USAID-PBSP-IMPACT is only limited to selected project sites. Although the PPhA established the PPhA Pharmacy DOTS Initiative Advocacy Group to sustain and scale-up the initiative, PDI has not been scaled-up systematically to involve pharmacists in the 85 chapters of the organization due to insufficient funds. “Business not-as-usual..”

Key Issue Affecting the Sector 2 Limited monitoring and evaluation of pharmacy contribution to TB elimination including compliance to policies, NO PRESCRITION NO DISPENSING and use of TB Referral Logbook due to limited manpower “Business not-as-usual..”

Key Issue Affecting the Sector 3 Insufficient documentation and sharing of experiences and lessons learnt to identify and scale-up successful best practice models for the engagement of the pharmacy sector. “Business not-as-usual..”

“Business not-as-usual..” Resources Available 85 Regional and local chapters 15, 000 members Find, Treat, Report “Business not-as-usual..”

“Business not-as-usual..” Thank You! “Business not-as-usual..”